TRDA Entrada Therapeutics, Inc.

NASDAQ
$6.80

Entrada Therapeutics, Inc. (TRDA) Hedge Fund Activity

This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.

Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.

Hedge fund breadth
+26.32
12 buyers / 7 sellers
STRONG BUYING
Funds compared
21
funds with comparable TRDA positions
20 current holders · 17 prior-quarter holders
Net share change
+1.49M
+1.72M added, -227.7K cut
Position activity
4 new 8 increased 6 reduced 1 exited

Most significant moves

Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.

Fund Action Shares changed Change Est. value Portfolio wt. Score
Point72 Asset Management, L.P. New +28.5K — $209.8K 0.0% 59
MARSHALL WACE, LLP Long/Short Sold Out -53.8K -100.0% $395.7K 0.0% 56
Voleon Capital Management Quant New +25.3K — $186.4K 0.0% 51
Nantahala Capital Management Event Long/Short Increased +441.8K +277.3% $3.3M 0.1% 50
CITADEL ADVISORS LLC Quant Increased +179.3K +83.4% $1.3M 0.0% 50
Graham Capital Management Quant Macro New +33.5K — $246.2K 0.0% 49
Y-Intercept Quant New +34.7K — $255.3K 0.0% 48
AQR Capital Management Long/Short Quant Increased +620.0K +780.0% $4.6M 0.0% 47
ExodusPoint Capital Management Long/Short Quant Increased +40.7K +337.3% $299.6K 0.0% 46
D. E. Shaw & Co., Inc. Quant Reduced -46.7K -59.0% $343.3K 0.0% 41

Most significant buyers

By move score, not size.

  • Point72 Asset Management, L.P. New · +28.5K
  • Voleon Capital Management New · +25.3K
  • Nantahala Capital Management Increased · +441.8K
  • CITADEL ADVISORS LLC Increased · +179.3K
  • Graham Capital Management New · +33.5K

Most significant sellers

By move score, not size.

  • MARSHALL WACE, LLP Sold Out · -53.8K
  • D. E. Shaw & Co., Inc. Reduced · -46.7K
  • ADAR1 Capital Management Reduced · -15.0K
  • Qube Research & Technologies Ltd Reduced · -26.6K
  • Woodline Partners LP Reduced · -70.4K

Hedge fund positions

Fund Tier Shares Previous Change Change % Portfolio wt. Action Score
Point72 Asset Management, L.P. 1 28.5K 0 +28.5K — 0.0% New 59
MARSHALL WACE, LLP 2 0 53.8K -53.8K -100.0% 0.0% Sold Out 56
Voleon Capital Management 3 25.3K 0 +25.3K — 0.0% New 51
Nantahala Capital Management 3 601.2K 159.3K +441.8K +277.3% 0.1% Increased 50
CITADEL ADVISORS LLC 1 394.3K 215.0K +179.3K +83.4% 0.0% Increased 50
Graham Capital Management 3 33.5K 0 +33.5K — 0.0% New 49
Y-Intercept 4 34.7K 0 +34.7K — 0.0% New 48
AQR Capital Management 3 699.5K 79.5K +620.0K +780.0% 0.0% Increased 47
ExodusPoint Capital Management 3 52.8K 12.1K +40.7K +337.3% 0.0% Increased 46
D. E. Shaw & Co., Inc. 1 32.4K 79.0K -46.7K -59.0% 0.0% Reduced 41
MILLENNIUM MANAGEMENT LLC 2 764.0K 519.4K +244.6K +47.1% 0.0% Increased 40
Trexquant Investment 3 140.1K 82.7K +57.4K +69.4% 0.0% Increased 37
ADAR1 Capital Management 3 15.5K 30.5K -15.0K -49.2% 0.0% Reduced 34
Qube Research & Technologies Ltd 2 60.9K 87.5K -26.6K -30.4% 0.0% Reduced 32
Woodline Partners LP 2 145.6K 216.0K -70.4K -32.6% 0.0% Reduced 31
RENAISSANCE TECHNOLOGIES LLC 1 191.0K 202.1K -11.1K -5.5% 0.0% Reduced 29
Quadrature Capital 3 13.3K 17.5K -4.3K -24.4% 0.0% Reduced 28
TWO SIGMA INVESTMENTS, LP 2 46.4K 44.6K +1.8K +4.0% 0.0% Increased 27
Brevan Howard Capital Management 3 34.0K 26.3K +7.6K +28.9% 0.0% Increased 26
Baker Bros. Advisors 1 5.1M 5.1M 0 +0.0% 0.2% Unchanged 27
Moore Capital Management 3 105.0K 105.0K 0 +0.0% 0.0% Unchanged 16

Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Hedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.